Skip to main content

Sathyanarayanan Sriram's Form 4 filing

Codiak BioSciences, Inc. (CDAK) · filed Sep 28, 2021

Accession no.
0000899243-21-038061
Filed
Sep 28, 2021
Trade date
Aug 6-9, 2021
Filing delay
53 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $54.2K. It was filed 53 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sathyanarayanan SriramCIK 0001867898Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseAcquired+1,300$3.29+$4,2771,300Direct
Aug 6, 2021Common StockSSaleDisposed−1,300$20.16−$26,2080Direct
Aug 9, 2021Common StockMOption exerciseAcquired+1,300$3.29+$4,2771,300Direct
Aug 9, 2021Common StockSSaleDisposed−751$21.31−$16,003.81549Direct
Aug 9, 2021Common StockSSaleDisposed−549$21.79−$11,962.710Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseAcquired+1,300$0.00$049,966Direct
Aug 9, 2021Common StockMOption exerciseAcquired+1,300$0.00$048,666Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)